Enliven Therapeutics ELVN
NASDAQ ELVN
$46.05 -0.46 (-0.99%)
As of: Sep 30, 2026 · 11:53 AM EDT

Enliven Therapeutics (ELVN) Enterprise Value (2020 - 2026)

Updated

Enliven Therapeutics (ELVN) posted Enterprise Value of $2.82 billion for Q2 2026, up 304.6% from $697.57 million a year earlier and up 45.9% from the prior quarter.

Analysis

Enliven Therapeutics (ELVN) Enterprise Value (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Enterprise Value at Enliven Therapeutics was $1.43 billion; for FY2025, it came in at $452.76 million, down 42.5% from FY2024.

  • Annual Enterprise Value shows a five-year compound annual growth rate of 15.7% (FY2020 to FY2025).
  • In prior years, Enliven Therapeutics' Enterprise Value was $787.63 million in FY2024 (+147.4%), $318.33 million in FY2023 (+895.4%), $31.98 million in FY2022 and -$41.54 million in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Enterprise Value in data going back to Q1 2020.
  • On a year-over-year basis, Enterprise Value increased in five of the last eight quarters, with growth averaging 100.6%.
  • The strongest year-over-year quarter for Enterprise Value in the past five years was Q4 2023, with growth of 895.4%; the weakest was Q3 2021, with a decline of 98.3%.
  • According to Business Quant data, Enterprise Value for the three prior quarters was $1.93 billion (Q1 2026), $452.76 million (Q4 2025) and $735.51 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Enliven Therapeutics 3.37 Bn 3.37 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.82 Bn
Mar 31, 2026 1.93 Bn
Dec 31, 2025 452.76 Mn
Sep 30, 2025 735.51 Mn
Jun 30, 2025 697.57 Mn
Mar 31, 2025 675.53 Mn
Dec 31, 2024 787.63 Mn
Sep 30, 2024 915.04 Mn
Jun 30, 2024 790.05 Mn
Mar 31, 2024 502.40 Mn
Dec 31, 2023 318.33 Mn
Sep 30, 2023 299.38 Mn
Jun 30, 2023 562.03 Mn
Mar 31, 2023 113.37 Mn
Dec 31, 2022 31.98 Mn
Sep 30, 2022 -33.04 Mn
Jun 30, 2022 -90.29 Mn
Mar 31, 2022 -86.87 Mn
Dec 31, 2021 -41.54 Mn
Sep 30, 2021 4.37 Mn
API Access

Enliven Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=ELVN&period=max&api_key=YOUR_API_KEY